Literature DB >> 560905

Growing human sarcomas in culture.

J Sethi, Y Hirshaut, S I Hajdu, L G Clements.   

Abstract

Efforts to establish human soft tissue and bone sarcomas in long-term cultures are described. Of 49 attempts 22 (45%) were successful, yielding cells that proliferated in vitro for 6 months or longer. Infrequent medium changes, maintenance of pH in physiologic range and avoidance of early trypsinization all appear to be important for survival of explanted cells and their initial growth under culture conditions. Cytologic criteria can be used to confirm that cells in established lines derive from malignant mesenchymal cells present in the tumors of origin.

Entities:  

Mesh:

Year:  1977        PMID: 560905     DOI: 10.1002/1097-0142(197708)40:2<744::aid-cncr2820400223>3.0.co;2-r

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  5 in total

1.  Cytoskeletal characteristics of myofibroblasts in benign neoplastic and reactive fibroblastic lesions.

Authors:  T Hasegawa; T Hirose; E Kudo; J Abe; K Hizawa
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1990

2.  Benign mesenchymal stromal cells in human sarcomas.

Authors:  Alexei Morozov; Robert J Downey; John Healey; Andre L Moreira; Emil Lou; Anna Franceschino; Yildirim Dogan; Roland Leung; Mark Edgar; Michael LaQuaglia; Robert G Maki; Malcolm A S Moore
Journal:  Clin Cancer Res       Date:  2010-12-01       Impact factor: 12.531

3.  Establishment and characterization of C-type RNA virus-producing cell lines from radiation-induced murine osteosarcomas.

Authors:  V Erfle; S Schulte-Overberg; K H Marquart; I D Adler; A Luz
Journal:  J Cancer Res Clin Oncol       Date:  1979-06-08       Impact factor: 4.553

4.  Reversible acquisition of a host cell surface membrane antigen by Trypanosoma cruzi.

Authors:  Q Chess; A M Acosta; J K Sethi; C A Santos-Buch
Journal:  Infect Immun       Date:  1983-04       Impact factor: 3.441

5.  Characterization of human sarcoma antigen S3.

Authors:  J K Sethi; Y Hirshaut
Journal:  Br J Cancer       Date:  1981-03       Impact factor: 7.640

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.